Intraventricular Stasis In Cardiovascular Disease (ISBIFLOW)
Personalizing The Risk Of Stroke And Silent Brain Infarct In Cardiovascular Disease
Sponsor: Hospital Clinic of Barcelona
This observational or N/A phase trial investigates Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy and is currently completed. Hospital Clinic of Barcelona leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Oct 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Mar 2022 — Oct 2023 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Oct 2021 — Mar 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Clinic of Barcelona
- Hospital General Universitario Gregorio Marañon
- University of Salamanca
For direct contact, visit the study record on ClinicalTrials.gov .